Indefinite Delivery Contract SPE2DX15D1017

The key products and services being delivered under this Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) are a comprehensive range of pharmaceutical and medical supplies. Awarded to Amerisourcebergen Drug Corp, the single-award IDC is valued at up to $999,999,999 and runs through December 2025. It serves as the primary vehicle for the company to provide medications, vaccines, syringes, vials, and other critical medical commodities to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract covers a broad spectrum of therapeutic areas, including cardiovascular health, diabetes management, mental health, pain relief, infectious disease prevention, and general medical care. Task orders under the IDC demonstrate the diverse pharmaceutical and medical supply requirements of the DLA and other federal agencies, with delivery of products such as Xarelto, Vimpat, Fluvoxamine, Myrbetriq, Xeljanz, Trulicity, Humira, and numerous other branded and generic drugs. The contract award did not utilize any set-aside requirements, indicating open competition for the provision of these essential medical products and services to the U.S. government.